Diego Centonze

32.7k total citations · 3 hit papers
487 papers, 23.3k citations indexed

About

Diego Centonze is a scholar working on Cellular and Molecular Neuroscience, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Diego Centonze has authored 487 papers receiving a total of 23.3k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Cellular and Molecular Neuroscience, 197 papers in Pathology and Forensic Medicine and 118 papers in Molecular Biology. Recurrent topics in Diego Centonze's work include Multiple Sclerosis Research Studies (194 papers), Neuroscience and Neuropharmacology Research (163 papers) and Neuroinflammation and Neurodegeneration Mechanisms (66 papers). Diego Centonze is often cited by papers focused on Multiple Sclerosis Research Studies (194 papers), Neuroscience and Neuropharmacology Research (163 papers) and Neuroinflammation and Neurodegeneration Mechanisms (66 papers). Diego Centonze collaborates with scholars based in Italy, United States and United Kingdom. Diego Centonze's co-authors include Giorgio Bernardi, Paolo Calabresi, Paolo Gubellini, Silvia Rossi, Antonio Pisani, Barbara Picconi, Alessandra Musella, Mauro Maccarrone, Fabio Buttari and Antonio Pisani and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Diego Centonze

472 papers receiving 23.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression

2007 964 citations Giovanna Borsellino, Diego Centonze et al. profile →
Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia

2003 674 citations Diego Centonze, Giorgio Bernardi et al. profile →
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

2022 104 citations Diego Centonze, Paolo Gallo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego Centonze Italy	81	10.2k	6.4k	4.8k	4.7k	4.6k	487	23.3k
Giorgio Bernardi Italy	97	19.1k 1.9×	10.6k 1.7×	8.8k 1.8×	2.2k 0.5×	5.9k 1.3×	615	35.2k
Margaret M. Esiri United Kingdom	79	3.4k 0.3×	4.7k 0.7×	3.6k 0.7×	3.0k 0.6×	3.8k 0.8×	288	21.2k
Fulton T. Crews United States	74	7.4k 0.7×	5.0k 0.8×	1.7k 0.3×	1.6k 0.3×	6.8k 1.5×	338	20.7k
Frank R. Sharp United States	87	7.3k 0.7×	12.3k 1.9×	4.1k 0.8×	1.2k 0.3×	5.4k 1.2×	376	27.7k
Alan I. Faden United States	94	8.7k 0.9×	11.1k 1.7×	8.4k 1.8×	4.8k 1.0×	4.5k 1.0×	399	28.1k
Michael A. Moskowitz United States	94	7.6k 0.7×	12.8k 2.0×	4.4k 0.9×	2.9k 0.6×	8.6k 1.9×	230	35.7k
Paolo Calabresi Italy	98	18.3k 1.8×	9.9k 1.5×	11.5k 2.4×	1.9k 0.4×	4.1k 0.9×	632	34.1k
Stephen W. Scheff United States	75	6.4k 0.6×	6.5k 1.0×	4.1k 0.9×	1.7k 0.4×	3.4k 0.7×	184	20.0k
Alison Goate United States	91	5.4k 0.5×	12.2k 1.9×	3.2k 0.7×	1.6k 0.3×	4.8k 1.0×	431	30.4k
Bertil B. Fredholm Sweden	93	12.8k 1.3×	13.9k 2.2×	1.9k 0.4×	1.3k 0.3×	3.6k 0.8×	528	36.2k

Countries citing papers authored by Diego Centonze

Since Specialization

Citations

This map shows the geographic impact of Diego Centonze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Centonze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Centonze more than expected).

Fields of papers citing papers by Diego Centonze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Centonze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Centonze. The network helps show where Diego Centonze may publish in the future.

Co-authorship network of co-authors of Diego Centonze

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Centonze. A scholar is included among the top collaborators of Diego Centonze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Centonze. Diego Centonze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guadalupi, Livia, Valentina Vanni, Sara Balletta, et al.. (2024). Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. Journal of Neuroinflammation. 21(1). 128–128. 8 indexed citations

Capone, Fioravante, Shalom Haggiag, Luca Prosperini, et al.. (2024). Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation study. Cerebral Cortex. 34(8). 1 indexed citations

Tacchino, Andrea, Michela Ponzio, Paolo Confalonieri, et al.. (2023). An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study. JMIR Serious Games. 11. e41371–e41371. 1 indexed citations

Ferese, Rosangela, Simona Scala, Antonio Suppa, et al.. (2023). Cohort analysis of novel SPAST variants in SPG4 patients and implementation of in vitro and in vivo studies to identify the pathogenic mechanism caused by splicing mutations. Frontiers in Neurology. 14. 1296924–1296924. 3 indexed citations

Romigi, Andrea, et al.. (2023). Muscle atonia index during multiple sleep latency test: A possible marker to differentiate narcolepsy from other hypersomnias. Clinical Neurophysiology. 149. 25–31.

Dolcetti, Ettore, Antonio Bruno, Luana Gilio, et al.. (2022). The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis. Genes. 13(2). 332–332. 10 indexed citations

Femiano, Cinzia, Rosangela Ferese, Diego Centonze, et al.. (2021). A Large Family with p.Arg554His Mutation in ABCD1: Clinical Features and Genotype/Phenotype Correlation in Female Carriers. Genes. 12(5). 775–775. 3 indexed citations

Rieckmann, Peter, Diego Centonze, Gavin Giovannoni, et al.. (2021). Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice. Therapeutic Advances in Neurological Disorders. 14. 4203339386–4203339386. 11 indexed citations

Bianco, Assunta, Matteo Lucchini, Rocco Totaro, et al.. (2021). Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients. Neurotherapeutics. 18(4). 2598–2607. 16 indexed citations

10.

Bassi, Mario Stampanoni, Fabio Buttari, Ilaria Simonelli, et al.. (2020). A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes. 11(10). 1152–1152. 6 indexed citations

11.

Musella, Alessandra, Antonietta Gentile, Livia Guadalupi, et al.. (2020). Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis. Cells. 9(5). 1290–1290. 26 indexed citations

12.

Mandolesi, Georgia, Silvia Bullitta, Diego Fresegna, et al.. (2019). Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination. Neurobiology of Disease. 129. 102–117. 52 indexed citations

13.

Nicoletti, Carolina Gabri, Doriana Landi, Fabrizia Monteleone, et al.. (2019). Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis. CNS Drugs. 33(11). 1133–1139. 9 indexed citations

14.

Prosperini, Luca, Pietro Annovazzi, Marco Capobianco, et al.. (2015). Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads. Multiple Sclerosis Journal. 21(13). 1713–1722. 19 indexed citations

15.

Cencioni, Maria Teresa, Giovanna Borsellino, Marco De Bardi, et al.. (2015). FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death and Disease. 6(5). e1741–e1741. 33 indexed citations

16.

Maccarrone, Mauro, Silvia Rossi, Monica Bari, et al.. (2010). Abnormal mGlu 5 Receptor/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA. Neuropsychopharmacology. 35(7). 1500–1509. 94 indexed citations

17.

Mori, Francesco, Giacomo Koch, Calogero Foti, Giorgio Bernardi, & Diego Centonze. (2009). The use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of spasticity. Progress in brain research. 175. 429–439. 52 indexed citations

18.

Centonze, Diego, Silvia Rossi, Laura Boffa, et al.. (2004). CSF from MS patients can induce acute conduction block in the isolated optic nerve. European Journal of Neurology. 12(1). 45–48. 4 indexed citations

19.

Calabresi, Paolo, Diego Centonze, Paolo Gubellini, Girolama Alessandra Marfia, & Giorgio Bernardi. (1999). Glutamate-triggered events inducing corticostriatal LTD. Neuropharmacology. 38(10). 8–8. 1 indexed citations

20.

Centonze, Diego, Paolo Gubellini, Giorgio Bernardi, & Paolo Calabresi. (1999). Permissive role of interneurons in corticostriatal synaptic plasticity. Brain Research Reviews. 31(1). 1–5. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact